Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
cicplatin and glutathione

cicplatin and glutathione A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer Frontiers | Bismuth Reduces Cisplatin-Induced

Frontiers Bismuth Reduces Cisplatin Induced Nephrotoxicity Via Enhancing Glutathione Conjugation and Vesicular Transport Is Glutathione the Major Cellular Target of Cisplatin? A Study of the Interactions of Cisplatin with Cancer Cell Extracts Journal of Medicinal Chemistry Multifaceted Roles of Glutathione and Glutathione Based Systems in Carcinogenesis and Anticancer Drug Resistance Elie Hatem, Nadine El Banna, Meng Er Huang, 2017 Coreshell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells Nanoscale (RSC Publishing) DOI:10.1039 C5NR04963F

SKU: 37674735745 · From chapuisstores.ch

4.0
USD22.14 USD61.14

Pay in 4 interest-free payments of $5.54 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Compositions according to claim 14 in the form of tablets obtained by direct compression

cicplatin and glutathione A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer Frontiers | Bismuth Reduces Cisplatin-Induced

Avoid smoking and alcohol consumption

cicplatin and glutathione A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer Frontiers | Bismuth Reduces Cisplatin-Induced

10.1073/pnas.0601001103 Proc

cicplatin and glutathione A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer Frontiers | Bismuth Reduces Cisplatin-Induced

Science 299 , 10331036 (2003)

cicplatin and glutathione A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer Frontiers | Bismuth Reduces Cisplatin-Induced
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products